GlassScriptPhysician profile
Adam Kahn
NPI 1821388141
$1,016.10
in general payments reported to CMS, 2019-2025
14 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $258 · 2023: $272 · 2024: $128 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $513.13 | 2021-2025 | Euflexxa |
| Bioventus LLC | $101.24 | 2022-2025 | Durolane, Durolane, Xcell |
| Kowa Pharmaceuticals America, INC. | $61.17 | 2022-2023 | Seglentis |
| Depuy Synthes Sales INC. | $60.16 | 2021-2025 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $58.45 | 2022-2024 | Zilretta, Iovera, Exparel |
| Endo Pharmaceuticals INC. | $44.12 | 2022-2023 | Xiaflex |
| Abbvie INC. | $32.31 | 2023 | |
| Averitas Pharma INC. | $31.07 | 2023 | Qutenza |
| Grt US Holding, INC. | $30.86 | 2022 | |
| Boston Scientific Corporation | $20.22 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.59 | 2025 | Strensiq |
| Sanofi-Aventis U.S. LLC | $15.88 | 2022 | |
| Pacira Therapeutics, INC. | $14.91 | 2021 | |
| Amgen INC. | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.